Patient Leaflet Updated 24-May-2024 | Glenmark Pharmaceuticals Europe Ltd
Fenhuma 100, 200, 300, 400, 600, 800 microgram sublingual tablets
Fenhuma 100 microgram sublingual tablets
Fenhuma 200 microgram sublingual tablets
Fenhuma 300 microgram sublingual tablets
Fenhuma 400 microgram sublingual tablets
Fenhuma 600 microgram sublingual tablets
Fenhuma 800 microgram sublingual tablets
fentanyl
1. What Fenhuma is and what it is used for
2. What you need to know before you take Fenhuma
3. How to take Fenhuma
4. Possible side effects
5. How to store Fenhuma
6. Contents of the pack and other information
This medicine contains fentanyl which is an opioid, which can cause addiction. You can get withdrawal symptoms if you stop taking it suddenly.
This medicine has been prescribed for you for treatment for adults who must already regularly be taking strong pain-relieving medicine (opioids) for their persistent cancer pain, but require treatment for their breakthrough pain.
It contains the fentanyl which belongs to a class of medicines called opioids, which are ‘pain relievers’. This medicine has been prescribed to you and should not be given to anyone else. Opioids can cause addiction and you may get withdrawal symptoms if you stop taking it suddenly. Your prescriber should have explained how long you will be taking it for and when it is appropriate to stop, how to do this safely.
Breakthrough pain is pain which occurs suddenly, even though you have taken or used your usual opioid pain-relieving medicine.
Fentanyl is a strong opioid and should not be used unless you have previously been prescribed other opioids.
This particular formulation is highly addictive. Contact your prescriber if you or a family member has concerns regarding use of this medicine.
Talk to your doctor or pharmacist before taking Fenhuma if you have or have recently had any of the following, as your doctor will need to take account of these when prescribing your dose:
Taking this medicine regularly, particularly for a long time, can lead to addiction. Your prescriber should have explained how long you will be taking it for and when it is appropriate to stop, how to do this safely.
Rarely, increasing the dose of this medicine can make you more sensitive to pain. If this happens, you need to speak to your prescriber about your treatment.
Addiction can cause withdrawal symptoms when you stop taking this medicine. Withdrawal symptoms can include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, loss of appetite, shaking, shivering or sweating. Your prescriber will discuss with you how to gradually reduce your dose before stopping the medicine. It is important that you do not stop taking the medicine suddenly as you will be more likely to experience withdrawal symptoms.
Opioids should only be used by those they are prescribed for. Do not give your medicine to anyone else. Taking higher doses or more frequent doses of opioid, may increase the risk of addiction. Overuse and misuse can lead to overdose and/or death.
When taking Fenhuma, inform your doctor or dentist that you are taking this medicine, if:
Long-term use and tolerance
This medicine contains fentanyl which is an opioid medicine. Repeated use of opioid painkillers can result in the drug being less effective (you become accustomed to it, known as drug tolerance). You may also become more sensitive to pain while using Fenhuma. This is known as hyperalgesia. Increasing the dose of Fenhuma may help to further reduce your pain for a while, but it may also be harmful. If you notice that your medicine becomes less effective, talk to your doctor. Your doctor will decide whether it is better for you to increase the dose or to gradually decrease your use of Fenhuma.
Dependence and addiction
Repeated use of Fenhuma can also lead to dependence, abuse and addiction which may result in life-threatening overdose. The risk of these side effects can increase with a higher dose and longer duration of use. Dependence or addiction can make you feel that you are no longer in control of how much medicine you need to use or how often you need to use it. You might feel that you need to carry on using your medicine, even when it doesn’t help to relieve your pain. The risk of becoming dependent or addicted varies from person to person.
You may have a greater risk of becoming dependent or addicted on Fenhuma if:
If you notice any of the following signs whilst using Fenhuma, it could be a sign that you have become dependent or addicted.
If you notice any of these signs, speak to your doctor to discuss the best treatment pathway for you, including when it is appropriate to stop and how to stop safely.
Sleep-related breathing disorders
Fenhuma can cause sleep-related breathing disorders such as sleep apnoea (breathing pauses during sleep) and sleep related hypoxemia (low oxygen level in the blood). The symptoms can include breathing pauses during sleep, night awakening due to shortness of breath, difficulties in maintaining sleep or excessive drowsiness during the day. If you or another person observe these symptoms, contact your doctor. A dose reduction may be considered by your doctor.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines (other than your regular opioid pain-relieving medicine).
Some medicines may increase or decrease the effects of Fenhuma. Therefore, if you start, change the dose of, or stop therapy with the following medication tell your doctor as they may need to adjust your dose of Fenhuma:
Fenhuma may add to the effect of medicines that make you feel sleepy (sedative medicines), including:
Use of Fenhuma at the same time as medicines that make you feel sleepy (sedative medicines), such as benzodiazepines, increases the risk of drowsiness, difficulties in breathing (respiratory depression), coma and may be life-threatening. Because of this, use of Fenhuma together with sedative medicines should only be considered when other treatment options are not possible.
However, if your doctor does prescribe Fenhuma together with sedative medicines, the dose and duration of treatment should be limited by your doctor.
Please tell your doctor about all sedative medicines you are taking, and follow your doctor’s dose recommendation closely. It could be helpful to inform friends or relatives to be aware of the signs and symptoms stated above. Contact your doctor when experiencing such symptoms.
The risk of certain other side effects increases if you are taking medicines such as certain antidepressants or antipsychotics. Fenhuma may interact with these medicines and you may experience mental status changes (e.g. agitation, hallucinations, coma), and other effects, such as body temperature above 38°C, increase in heart rate, unstable blood pressure, and exaggeration of reflexes, muscular rigidity, lack of coordination and/or gastrointestinal symptoms (e.g nausea, vomiting, diarrhoea). Your doctor will tell you whether Fenhuma is suitable for you.
Fenhuma can make some people feel drowsy. Do not consume alcohol without consulting your doctor as it might make you feel more drowsy than usual.
Do not drink grapefruit juice while you are prescribed Fenhuma treatment as it may increase the side effects of Fenhuma.
Pregnancy
Do not take Fenhuma if you are pregnant or think you might be pregnant unless you have discussed this with your prescriber and the benefits of treatment are considered to outweigh the potential harm to the baby.
If you use Fenhuma during pregnancy, your baby may become dependent and experience withdrawal symptoms after the birth which may need to be treated.
Do not take Fenhuma while you are breastfeeding as fentanyl passes into breast milk and will affect your baby.
Ask your doctor or pharmacist for advice before taking any medicine when pregnant or breast-feeding.
Fenhuma may impair your mental and/or physical ability to perform potentially hazardous tasks such as driving or operating machinery.
If you feel dizzy, sleepy or have blurred vision when you take Fenhuma, do not drive or use machinery.
Driving in the UK
This medicine can affect your ability to drive as it may make you sleepy or dizzy.
Do not drive while taking this medicine until you know how this medicine affects you.
It may be an offence to drive if your ability to drive safely is affected by taking this medicine.
There is further information for patients who are intending to drive in the UK - go to https://www.gov.uk/drug-driving-law
Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium- free’.
Before starting treatment and regularly during treatment, your doctor will also discuss with you what you may expect from using Fenhuma, when and how long you need to take it, when to contact your doctor, and when you need to stop it (see also section 2).
Your prescriber should have discussed with you; how long the course of tablets will last. They will arrange a plan for stopping treatment. This will outline how to gradually reduce the dose and stop taking the medicine.
Before taking Fenhuma for the first time your doctor will explain how Fenhuma should be taken to effectively treat your breakthrough pain.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
This product should ONLY be used by you according to your doctor’s instructions. It should not be used by anyone else as it could present a SERIOUS risk to their health, especially in children.
Fenhuma is a different type of medication from other medicines you may have used to treat your breakthrough pain. You must always use the dose of Fenhuma as prescribed by your doctor – this may be a different dose from that which you have used with other medicines for breakthrough pain.
For Fenhuma to work successfully, your doctor will need to identify the most appropriate dose for treating your breakthrough pain. Fenhuma is available in a range of strengths. You may need to try different strengths of Fenhuma over a number of episodes of breakthrough pain to find the most appropriate dose. Your doctor will help you do this and will work with you to find the best dose to use.
If you do not get adequate pain relief from one dose your doctor may ask you to take an extra dose to treat an episode of breakthrough pain. Do not take a second dose unless your doctor tells you to, as this may result in overdose.
Sometimes your doctor may advise you to take a dose which consists of more than one tablet at a time.
Only do this if directed by your doctor.
Wait at least 2 hours from taking your last dose before treating your next episode of breakthrough pain with Fenhuma.
Once you and your doctor have found a dose of Fenhuma that controls your breakthrough pain you should take this dose no more than four times a day. A dose of Fenhuma may consist of more than one tablet.
Wait at least 2 hours from taking your last dose before treating your next episode of breakthrough pain with Fenhuma.
If you think that the dose of Fenhuma that you are using is not controlling your breakthrough pain satisfactorily tell your doctor, as he may need to adjust your dose.
You must not change your dose of Fenhuma unless directed by your doctor.
Fenhuma should be used sublingually. This means that the tablet should be placed under the tongue where it dissolves rapidly in order to allow fentanyl to be absorbed across the lining of the mouth. Once absorbed, fentanyl starts to work to relieve pain.
When you get an episode of breakthrough pain, take the dose advised by your doctor as follows:
Symptoms of overdose include:
An overdose may also result in a brain disorder known as toxic leukoencephalopathy.
If these occur, seek emergency medical help immediately.
If you think someone has taken Fenhuma by accident seek emergency medical help immediately.
Do not suddenly stop taking this medicine. If you want to stop taking this medicine, discuss this with your prescriber first. They will tell you how to do this, usually by reducing the dose gradually so that any unpleasant withdrawal effects are kept to a minimum. Withdrawal symptoms such as restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating may occur if you suddenly stop taking this medicine.
You should discontinue Fenhuma when you no longer have any breakthrough pain. You must however continue to take your usual opioid pain relieving medicine to treat your persistent cancer pain as advised by your doctor. You may experience withdrawal symptoms similar to the possible side effects of Fenhuma when discontinuing Fenhuma. If you experience withdrawal symptoms or if you are concerned about your pain relief you should contact your doctor. Your doctor will evaluate if you need medicine to reduce or eliminate the withdrawal symptoms.
There is a risk that you may become addicted to or dependent on these tablets (a need to keep taking the medicines). If you take these for a long time you can become used to the effects and you may need to take higher doses to control your pain.
You should not suddenly stop taking these tablets unless your doctor tells you to. If you want to stop taking you tablets, discuss this with your doctor first. They will tell you how to do this, usually by reducing the dose gradually so you do not experience unpleasant effects. If you suddenly stop taking these tablets you may get withdrawal symptoms such as
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side-effects, although not everybody gets them.
If you start to feel unusually or extremely sleepy or your breathing becomes slow or shallow, you or your carer should immediately contact your doctor or local hospital for emergency help (see also section 3 “If you take more Fenhuma than you should”).
Very common side effects (may affect more than 1 in 10 people) include:
Common side effects (may affect up to 1 in 10 people) include:
Uncommon side effects (may affect up to 1 in 100 people) include:
Not known: (frequency cannot be estimated from the available data)
Prolonged treatment with fentanyl during pregnancy may cause withdrawal symptoms in the newborn which can be life-threatening (see section 2).
Drug Withdrawal
When you stop taking Fenhuma, you may experience drug withdrawal symptoms, which include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating.
If you notice any of the following signs whilst taking Fenhuma, it could be a sign that you have become addicted.
If you notice any of these signs, it is important you talk to your prescriber
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed below. By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store
The pain-relieving medicine in Fenhuma is very strong and could be life-threatening if taken accidentally by a child. Fenhuma must be kept out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister after EXP. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
It is recommended to keep Fenhuma in a locked storage space.
Store this medicine in a safe and secure place, where other people cannot access it. It can cause serious harm and be fatal to people who may take this medicine by accident, or intentionally when it has not been prescribed for them.
Any unused product should be taken, if possible, to your pharmacist to be disposed of safely. Do not throw away any medicines via wastewater or household waste. These measures will help protect the environment.
The active substance is fentanyl. One sublingual tablet contains:
100 micrograms fentanyl (as citrate)
200 micrograms fentanyl (as citrate)
300 micrograms fentanyl (as citrate)
400 micrograms fentanyl (as citrate)
600 micrograms fentanyl (as citrate)
800 micrograms fentanyl (as citrate)
The other ingredients are mannitol (E421), silicified microcrystalline cellulose, croscarmellose sodium and magnesium stearate.
Fenhuma is a small white sublingual tablet to be inserted under the tongue. It comes in a range of different strengths and shapes. Your doctor will prescribe the strength (shape) and number of tablets suitable for you.
The 100 microgram tablet is a 6 mm white round tablet
The 200 microgram tablet is a 7 x 4.5 mm white oval-shaped tablet
The 300 microgram tablet is a 6.2 x 6.2 mm white triangle-shaped tablet
The 400 microgram tablet is a 8.5 x 6.5 mm white diamond-shaped tablet
The 600 microgram tablet is a 8.5 x 6 mm white “D”-shaped tablet
The 800 microgram tablet is a 10 x 6 mm white capsule-shaped tablet
Fenhuma 100, 200, 300 and 400 is available in perforated or non-perforated blisters in cartons of 10, 10 x 1, 30 and 30 x 1 tablets.
Fenhuma 600 and 800 is available in perforated or non-perforated blisters in cartons of 30 and 30 x 1 tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
This leaflet was last revised in May 2024.
Building 2, Croxley Park, Watford, WD18 8YA
+44 (0)1923 251137
www.glenmarkpharma.com
+44 (0)1923 202 950
0800 458 0383
+44 (0)1923 202 950